In Vitro Hemodynamic Evaluation of an Adult Pulsatile Extracorporeal Membrane Oxygenation System

Shigang Wang, Morgan Moroi, Christoph Brehm, Allen Kunselman, Akif Undar

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The objective of this study was to evaluate a pulsatile extracorporeal membrane oxygenation (ECMO) system in terms of hemodynamic energy generation and transmission under various pulsatile amplitudes, flow rates, and pseudopatient pressures in a simulated adult ECMO circuit. Surplus hemodynamic energy (SHE), a measure of the quality of pulsatility, was used to quantify pulsatile flow. The circuit consisted of an i-cor diagonal pump, an adult XLung oxygenator, a 21 Fr Medtronic Biomedicus femoral arterial cannula, a 23/25 Fr Sorin RAP femoral venous cannula, and 3/8 in ID tubing for both arterial and venous lines. The circuit was primed with lactated Ringer's solution and then packed red blood cells (hematocrit 37%). Trials were conducted at 36°C with flow rates of 2-5 L/min (1 L/min increments) under nonpulsatile and pulsatile mode with pulsatile amplitudes of 1000–5000 rpm (1000 rpm increments). The pseudopatient pressure was maintained at 40–100 mm Hg (20 mm Hg increments). Real-time pressure and flow data were recorded for analysis using a custom-made data acquisition system. There was no SHE generated by the pump under nonpulsatile mode. Under pulsatile mode, SHE levels increased with increasing pulsatile amplitude and pseudopatient pressure (P < 0.01) but decreased with increasing flow rate. SHE levels were significantly higher at flow rates of 2–4 L/min. In addition, the XLung oxygenator had acceptable pressure drops (36.1–104.9 mm Hg) and percentages of total hemodynamic energy loss (19.6–43.9%) during all trials. The novel pulsatile ECMO system can create nonpulsatile and pulsatile flow in an adult ECMO model. However, pulsatility gradually weakened with increasing flow rates. Pulsatile amplitude settings were found to have a great impact on pulsatility.

Original languageEnglish (US)
Pages (from-to)E234-E245
JournalArtificial Organs
Volume42
Issue number9
DOIs
StatePublished - Sep 1 2018

Fingerprint

Extracorporeal Membrane Oxygenation
Oxygenation
Hemodynamics
Membranes
Pulsatile Flow
Flow rate
Oxygenators
Pressure
Pulsatile flow
Thigh
Electron energy levels
Networks (circuits)
Pumps
Vascular Access Devices
Tubing
Hematocrit
Information Systems
Pressure drop
In Vitro Techniques
Data acquisition

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering

Cite this

@article{55bb53ebd13a46abb17fd637a6f70257,
title = "In Vitro Hemodynamic Evaluation of an Adult Pulsatile Extracorporeal Membrane Oxygenation System",
abstract = "The objective of this study was to evaluate a pulsatile extracorporeal membrane oxygenation (ECMO) system in terms of hemodynamic energy generation and transmission under various pulsatile amplitudes, flow rates, and pseudopatient pressures in a simulated adult ECMO circuit. Surplus hemodynamic energy (SHE), a measure of the quality of pulsatility, was used to quantify pulsatile flow. The circuit consisted of an i-cor diagonal pump, an adult XLung oxygenator, a 21 Fr Medtronic Biomedicus femoral arterial cannula, a 23/25 Fr Sorin RAP femoral venous cannula, and 3/8 in ID tubing for both arterial and venous lines. The circuit was primed with lactated Ringer's solution and then packed red blood cells (hematocrit 37{\%}). Trials were conducted at 36°C with flow rates of 2-5 L/min (1 L/min increments) under nonpulsatile and pulsatile mode with pulsatile amplitudes of 1000–5000 rpm (1000 rpm increments). The pseudopatient pressure was maintained at 40–100 mm Hg (20 mm Hg increments). Real-time pressure and flow data were recorded for analysis using a custom-made data acquisition system. There was no SHE generated by the pump under nonpulsatile mode. Under pulsatile mode, SHE levels increased with increasing pulsatile amplitude and pseudopatient pressure (P < 0.01) but decreased with increasing flow rate. SHE levels were significantly higher at flow rates of 2–4 L/min. In addition, the XLung oxygenator had acceptable pressure drops (36.1–104.9 mm Hg) and percentages of total hemodynamic energy loss (19.6–43.9{\%}) during all trials. The novel pulsatile ECMO system can create nonpulsatile and pulsatile flow in an adult ECMO model. However, pulsatility gradually weakened with increasing flow rates. Pulsatile amplitude settings were found to have a great impact on pulsatility.",
author = "Shigang Wang and Morgan Moroi and Christoph Brehm and Allen Kunselman and Akif Undar",
year = "2018",
month = "9",
day = "1",
doi = "10.1111/aor.13156",
language = "English (US)",
volume = "42",
pages = "E234--E245",
journal = "Artificial Organs",
issn = "0160-564X",
publisher = "Wiley-Blackwell",
number = "9",

}

In Vitro Hemodynamic Evaluation of an Adult Pulsatile Extracorporeal Membrane Oxygenation System. / Wang, Shigang; Moroi, Morgan; Brehm, Christoph; Kunselman, Allen; Undar, Akif.

In: Artificial Organs, Vol. 42, No. 9, 01.09.2018, p. E234-E245.

Research output: Contribution to journalArticle

TY - JOUR

T1 - In Vitro Hemodynamic Evaluation of an Adult Pulsatile Extracorporeal Membrane Oxygenation System

AU - Wang, Shigang

AU - Moroi, Morgan

AU - Brehm, Christoph

AU - Kunselman, Allen

AU - Undar, Akif

PY - 2018/9/1

Y1 - 2018/9/1

N2 - The objective of this study was to evaluate a pulsatile extracorporeal membrane oxygenation (ECMO) system in terms of hemodynamic energy generation and transmission under various pulsatile amplitudes, flow rates, and pseudopatient pressures in a simulated adult ECMO circuit. Surplus hemodynamic energy (SHE), a measure of the quality of pulsatility, was used to quantify pulsatile flow. The circuit consisted of an i-cor diagonal pump, an adult XLung oxygenator, a 21 Fr Medtronic Biomedicus femoral arterial cannula, a 23/25 Fr Sorin RAP femoral venous cannula, and 3/8 in ID tubing for both arterial and venous lines. The circuit was primed with lactated Ringer's solution and then packed red blood cells (hematocrit 37%). Trials were conducted at 36°C with flow rates of 2-5 L/min (1 L/min increments) under nonpulsatile and pulsatile mode with pulsatile amplitudes of 1000–5000 rpm (1000 rpm increments). The pseudopatient pressure was maintained at 40–100 mm Hg (20 mm Hg increments). Real-time pressure and flow data were recorded for analysis using a custom-made data acquisition system. There was no SHE generated by the pump under nonpulsatile mode. Under pulsatile mode, SHE levels increased with increasing pulsatile amplitude and pseudopatient pressure (P < 0.01) but decreased with increasing flow rate. SHE levels were significantly higher at flow rates of 2–4 L/min. In addition, the XLung oxygenator had acceptable pressure drops (36.1–104.9 mm Hg) and percentages of total hemodynamic energy loss (19.6–43.9%) during all trials. The novel pulsatile ECMO system can create nonpulsatile and pulsatile flow in an adult ECMO model. However, pulsatility gradually weakened with increasing flow rates. Pulsatile amplitude settings were found to have a great impact on pulsatility.

AB - The objective of this study was to evaluate a pulsatile extracorporeal membrane oxygenation (ECMO) system in terms of hemodynamic energy generation and transmission under various pulsatile amplitudes, flow rates, and pseudopatient pressures in a simulated adult ECMO circuit. Surplus hemodynamic energy (SHE), a measure of the quality of pulsatility, was used to quantify pulsatile flow. The circuit consisted of an i-cor diagonal pump, an adult XLung oxygenator, a 21 Fr Medtronic Biomedicus femoral arterial cannula, a 23/25 Fr Sorin RAP femoral venous cannula, and 3/8 in ID tubing for both arterial and venous lines. The circuit was primed with lactated Ringer's solution and then packed red blood cells (hematocrit 37%). Trials were conducted at 36°C with flow rates of 2-5 L/min (1 L/min increments) under nonpulsatile and pulsatile mode with pulsatile amplitudes of 1000–5000 rpm (1000 rpm increments). The pseudopatient pressure was maintained at 40–100 mm Hg (20 mm Hg increments). Real-time pressure and flow data were recorded for analysis using a custom-made data acquisition system. There was no SHE generated by the pump under nonpulsatile mode. Under pulsatile mode, SHE levels increased with increasing pulsatile amplitude and pseudopatient pressure (P < 0.01) but decreased with increasing flow rate. SHE levels were significantly higher at flow rates of 2–4 L/min. In addition, the XLung oxygenator had acceptable pressure drops (36.1–104.9 mm Hg) and percentages of total hemodynamic energy loss (19.6–43.9%) during all trials. The novel pulsatile ECMO system can create nonpulsatile and pulsatile flow in an adult ECMO model. However, pulsatility gradually weakened with increasing flow rates. Pulsatile amplitude settings were found to have a great impact on pulsatility.

UR - http://www.scopus.com/inward/record.url?scp=85054654105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054654105&partnerID=8YFLogxK

U2 - 10.1111/aor.13156

DO - 10.1111/aor.13156

M3 - Article

C2 - 29774551

AN - SCOPUS:85054654105

VL - 42

SP - E234-E245

JO - Artificial Organs

JF - Artificial Organs

SN - 0160-564X

IS - 9

ER -